About the Authors
- Ila R. Singh
-
* E-mail: ila.singh@path.utah.edu
Affiliation Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America
- John E. Gorzynski
-
Affiliation Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America
- Daria Drobysheva
-
Affiliation Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America
- Leda Bassit
-
Affiliation Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical Center, Decatur, Georgia, United States of America
- Raymond F. Schinazi
-
Affiliation Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical Center, Decatur, Georgia, United States of America
Competing Interests
RFS is a founder and major shareholder of RFS Pharma, LLC that is developing Amdoxovir clinically and he receives royalties from the sales of 3TC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: IRS RFS. Performed the experiments: JEG DD. Analyzed the data: IRS JEG LB RFS. Contributed reagents/materials/analysis tools: IRS RFS. Wrote the paper: IRS RFS.